Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1543)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular mechanisms of omega-3 fatty acids in the migraine headache. (2017/10/07) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Multimodal exercise training in multiple sclerosis: A randomized controlled trial in persons with substantial mobility disability. (2017/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current concepts in multiple sclerosis therapy. (2017/09/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Stem cells therapy: the future in the management of systemic sclerosis? A case report. (2017/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Secondary aneurysmal bone cyst in McCune-Albright syndrome. (2017/09/01) ♡
- Enrichment of Retroviral Sequences in Brain Tissue from Patients with Severe Demyelinating Diseases. (2017/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Caspases in retinal ganglion cell death and axon regeneration. (2017/07/03) ♡
- Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study. (2017/06/26) ♡
- [Experience with natalizumab-treatment at Semmelweis University]. (2017/05/30) ♡
- Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors. (2017/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D and multiple sclerosis: An update. (2017/05/01) ♡
- [Risk factors analysis for low back pain in patients with multiple sclerosis]. (2017/04/25) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness. (2017/04/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a. (2017/03/24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Multimodal, Nonpharmacologic Intervention Improves Mood and Cognitive Function in People with Multiple Sclerosis. (2017/03/01) ♡
- Access, delivery and perceived efficacy of physiotherapy and use of complementary and alternative therapies by people with progressive multiple sclerosis in the United Kingdom: An online survey. (2017/02/01) ♡
- Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. (2017/01/04) ♡
- Effect of Roux-en-Y gastric bypass and diet-induced weight loss on diabetic kidney disease in the Zucker diabetic fatty rat. (2017/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What is "Hyper" in the ALS Hypermetabolism? (2017/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rare Neurodegenerative Diseases: Clinical and Genetic Update. (2017/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Dimethyl fumarate (tecfidera) is the first line treatment choice in patients with remitting multiple sclerosis]. (2017/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Primary progressive multiple sclerosis: current issues of timely diagnosis]. (2017/01/01) ♡
- [The efficacy of the exoskeleton ExoAtlet to restore walking in patients with multiple sclerosis]. (2017/01/01) ♡
- Stemness Characteristics of Periodontal Ligament Stem Cells from Donors and Multiple Sclerosis Patients: A Comparative Study. (2017/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Effect of High Intensity Interval Training on Cardiovascular Fitness in People With Progressive Multiple Sclerosis. (2017-10-25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis (2017-09-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis (2017-09-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients (2017-08-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis (2017-07-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS) (2017-07-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis (2017-07-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. (2017-06-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Armergometry to Improve Mobility in MS (2017-05-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS (2017-05-03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis (2017-04-26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis (2017-03-27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of MD1003 in Spinal Progressive Multiple Sclerosis (2017-03-27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers (2017-03-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis (2017-03-21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS) (2017-02-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis (2017-01-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (2017-01-10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (2016-11-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis (2016-11-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. China Betaferon Adherence, Coping and Nurse Support Study (2016-09-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK. (2016-05-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis (2016-04-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS (2016-03-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe) (2016-03-28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Progressive Muscle Relaxation Effect on Sleep Quality, Depression and Stress in People With Multiple Sclerosis (2016-02-04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.